Znanstveni rad - Izvorni znanstveni rad
Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines

Hiršl, Lea; Brizić, Ilija; Jenuš, Tina; Juranić Lisnić, Vanda; Reichel, Johanna Julia; Jurković, Slaven; Krmpotić, Astrid; Jonjić, Stipan (2018)
Citirajte ovaj rad

Hiršl, L., Brizić, I., Jenuš, T., Juranić Lisnić, V., Reichel, J. J., Jurković, S. ... Jonjić, S. (2018). Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines. Frontiers in Immunology, 9.. doi: 10.3389/fimmu.2018.00991

Hiršl, Lea, et al. "Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines." Frontiers in Immunology, vol. 9, 2018. https://doi.org/10.3389/fimmu.2018.00991

Hiršl, Lea, Ilija Brizić, Tina Jenuš, Vanda Juranić Lisnić, Johanna Julia Reichel, Slaven Jurković, Astrid Krmpotić i Stipan Jonjić. "Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines." Frontiers in Immunology 9 (2018). https://doi.org/10.3389/fimmu.2018.00991

Hiršl, L., et al. (2018) 'Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines', Frontiers in Immunology, 9. doi: 10.3389/fimmu.2018.00991

Hiršl L, Brizić I, Jenuš T, Juranić Lisnić V, Reichel JJ, Jurković S, i sur.. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines. Frontiers in Immunology [Internet]. 07.05.2018. [pristupljeno 20.02.2020.];9. doi: 10.3389/fimmu.2018.00991

L. Hiršl, et al., "Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines", Frontiers in Immunology, vol. 9, Svibanj 2018. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:653520. [Citirano: 20.02.2020.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.